U.S. flag

An official website of the United States government

NM_000527.5(LDLR):c.508G>A (p.Asp170Asn) AND Hypercholesterolemia, familial, 1

Germline classification:
Uncertain significance (4 submissions)
Last evaluated:
Dec 13, 2023
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000211593.11

Allele description [Variation Report for NM_000527.5(LDLR):c.508G>A (p.Asp170Asn)]

NM_000527.5(LDLR):c.508G>A (p.Asp170Asn)

Gene:
LDLR:low density lipoprotein receptor [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
19p13.2
Genomic location:
Preferred name:
NM_000527.5(LDLR):c.508G>A (p.Asp170Asn)
HGVS:
  • NC_000019.10:g.11105414G>A
  • NG_009060.1:g.21034G>A
  • NM_000527.5:c.508G>AMANE SELECT
  • NM_001195798.2:c.508G>A
  • NM_001195799.2:c.385G>A
  • NM_001195800.2:c.314-1978G>A
  • NM_001195803.2:c.314-1151G>A
  • NP_000518.1:p.Asp170Asn
  • NP_000518.1:p.Asp170Asn
  • NP_001182727.1:p.Asp170Asn
  • NP_001182728.1:p.Asp129Asn
  • LRG_274t1:c.508G>A
  • LRG_274:g.21034G>A
  • LRG_274p1:p.Asp170Asn
  • NC_000019.9:g.11216090G>A
  • NM_000527.4:c.508G>A
Protein change:
D129N
Links:
dbSNP: rs139089530
NCBI 1000 Genomes Browser:
rs139089530
Molecular consequence:
  • NM_001195800.2:c.314-1978G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001195803.2:c.314-1151G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_000527.5:c.508G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001195798.2:c.508G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001195799.2:c.385G>A - missense variant - [Sequence Ontology: SO:0001583]
Observations:
5

Condition(s)

Name:
Hypercholesterolemia, familial, 1
Synonyms:
LDL RECEPTOR DISORDER; Hyperlipoproteinemia Type IIa; HYPER-LOW-DENSITY-LIPOPROTEINEMIA; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0007750; MedGen: C0745103; Orphanet: 391665; OMIM: 143890

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000266315Cardiovascular Biomarker Research Laboratory, Mayo Clinic - RIGHT
criteria provided, single submitter

(Mayo Cardiovascular Biomarkers Research Laboratory LDLR variant interpretation criteria, 2015)
Uncertain significance
(Aug 31, 2016)
germlineresearch

PubMed (1)
[See all records that cite this PMID]

Kullo Lab Assertion Criteria_01072016.pdf,

Citation Link,

SCV000268567Cardiovascular Genetics Laboratory, PathWest Laboratory Medicine WA - Fiona Stanley Hospital
no assertion criteria provided
Uncertain significance
(Oct 7, 2011)
germlineclinical testing

SCV000606140Laboratorium voor Moleculaire Diagnostiek Experimentele Vasculaire Geneeskunde, Academisch Medisch Centrum
no assertion criteria provided
Pathogenicgermlineresearch

SCV004820174All of Us Research Program, National Institutes of Health
criteria provided, single submitter

(ACMG Guidelines, 2015)
Uncertain Significance
(Dec 13, 2023)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyes1not providednot providednot providednot providedclinical testing
not providedgermlineunknown4not providednot provided108544not providedclinical testing, research
Whitegermlinenonot providednot providednot provided1013not providedresearch

Citations

PubMed

Variability in assigning pathogenicity to incidental findings: insights from LDLR sequence linked to the electronic health record in 1013 individuals.

Safarova MS, Klee EW, Baudhuin LM, Winkler EM, Kluge ML, Bielinski SJ, Olson JE, Kullo IJ.

Eur J Hum Genet. 2017 Apr;25(4):410-415. doi: 10.1038/ejhg.2016.193. Epub 2017 Feb 1.

PubMed [citation]
PMID:
28145427
PMCID:
PMC5386413

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From Cardiovascular Biomarker Research Laboratory, Mayo Clinic - RIGHT, SCV000266315.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1Whitenot providednot providednot providedresearch PubMed (1)

Description

MAF =<0.3%, likely pathogenic based on the integrative in-silico score; LDL-C >=160 mg/dL

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineno1013not providedassert pathogenicitynot providednot providednot providednot provided

From Cardiovascular Genetics Laboratory, PathWest Laboratory Medicine WA - Fiona Stanley Hospital, SCV000268567.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences

From Laboratorium voor Moleculaire Diagnostiek Experimentele Vasculaire Geneeskunde, Academisch Medisch Centrum, SCV000606140.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedresearchnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From All of Us Research Program, National Institutes of Health, SCV004820174.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided4not providednot providedclinical testing PubMed (1)

Description

This missense variant (also known as p.Asp149Asn in the mature protein) replaces aspartic acid with asparagine at codon 170 of the LDLR protein. Computational prediction is inconclusive regarding the impact of this variant on protein structure and function (internally defined REVEL score threshold 0.5 < inconclusive < 0.7, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has not been reported in individuals affected with familial hypercholesterolemia in the literature. This variant has been identified in 3/251270 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknown108544not providednot provided4not providednot providednot provided

Last Updated: Sep 1, 2024